Skip to Content
Merck

[Atenolol in treatment of patients with airway obstruction].

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego (1996-12-01)
R Chazan
ABSTRACT

It is well known that beta-2-blockers are contraindicated for patients with bronchial hyperactivity. Author discusses the clinical observations in relation to treatment with atenolol in circulatory system pathology.

MATERIALS
Product Number
Brand
Product Description

USP
Atenolol, United States Pharmacopeia (USP) Reference Standard
Atenolol, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Atenolol, ≥98% (TLC), powder